AMS - American Shared Hospital Services
NYSE
->
Healthcare
->
Medical Care Facilities
San Francisco,
United States
Type: Equity
AMS price evolution
AMS
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $4.85 | $4.64 | $5.33 | $4.77 |
| Inventory | ||||
| Total current assets | $20.46 | $20.37 | $20.08 | $19.57 |
| Long term investments | ||||
| Property, plant & equipment | $25.92 | $25.29 | $22.99 | $22.55 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $48.16 | $47.36 | $44.46 | $43.55 |
| Current liabilities | ||||
| Accounts payable | $0.32 | $0.35 | $0.3 | $0.25 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $10.78 | $10.05 | $6.76 | $5.25 |
| Long term debt | $11.04 | $10.45 | $11.08 | $11.49 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $25.54 | $25.25 | $22.56 | $21.64 |
| Shareholders' equity | ||||
| Retained earnings | $3.63 | $3.21 | $3.1 | $3.21 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4.33 | |||
| Short term investments | ||||
| Net receivables | $4.85 | $4.13 | $4.82 | $4.58 |
| Inventory | ||||
| Total current assets | $20.46 | $18.72 | $15.09 | $10.85 |
| Long term investments | ||||
| Property, plant & equipment | $25.92 | $23.8 | $28.93 | $30.44 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $32.8 | |||
| Total investments | ||||
| Total assets | $48.16 | $43.96 | $45.43 | $43.65 |
| Current liabilities | ||||
| Accounts payable | $0.32 | $0.23 | $0.75 | $0.68 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $10.78 | $5.17 | $5.89 | $12.38 |
| Long term debt | $11.04 | $12.21 | $14.32 | $3.44 |
| Total noncurrent liabilities | $7.62 | |||
| Total debt | ||||
| Total liabilities | $25.54 | $22.33 | $25.54 | $20 |
| Shareholders' equity | ||||
| Retained earnings | $3.63 | $3.02 | $1.69 | $1.5 |
| Other shareholder equity | $4.38 | |||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17.63 | $17.84 | $20.61 | $19.71 |
| Cost of revenue | ||||
| Gross Profit | $6.73 | $4.47 | $6.92 | $7.49 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $4.53 | $14.3 | $6.06 | $5.85 |
| Operating income | -$9.46 | $1.54 | $1.86 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.27 | -$1.74 | $0.13 | $0.45 |
| Interest expense | -$0.74 | $1.06 | $1.32 | $1.63 |
| Net income | ||||
| Net income | $0.19 | -$7.06 | $0.66 | $1.02 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$0.33 | -$0.1 | -$0.07 | -$1.67 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1.9 | -$0.29 | -$0.06 | -$0.66 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $3.4 | $3.7 | $0.13 | $3.94 |
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 |
|---|---|---|---|---|
| Net income | -$7.72 | $1.43 | $1.63 | |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $9.74 | $8.05 | $8.06 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$1.67 | -$2.39 | -$0.99 | -$1.53 |
| Financing activities | ||||
| Dividends paid | -$0.76 | -$0.94 | -$0.69 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$0.66 | -$4.81 | -$7.07 | -$7.25 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $3.94 | $2.55 | -$0.01 | -$0.71 |
News
Fundamentals
| Market cap | $19.03M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 6.30M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.90 |
| Quick ratio | N/A |